A nine amino-acid peptide derived from the Pl-subunit of the bovine GABAA receptor was used for immunization of mice and subsequent production of monoclonal antibodies (MAb). In view of the later immunocytochemical application of the MAb to sections of cat visual cortex, the MAb were characterized on similar tissue. The GABAA receptor was isolated by affinity chromatography of protein material obtained from cat cortical gray matter. The antibodies were characterized by SDS-PAGE, followed by immunoblotting and immunoadsorption. Immunocytochemical staining with the MAb revealed labeled cells throughout all layers of the ~ * Correspondence to: Prof. Dr. Frans Vandesande, Laboratory for Neuroendocrinology and Immunological Biotechnology, Zoological Institute, Katholieke Univeniteit Leuven, Naamsenraat 19, B-3000 Leuven, Belgium. cat visual cortex as well as within the white matter. The morphology of most stained cells in the white matter and of some cells in the cortical gray matter closely resembled that of astrocytes. Double immunocytochemical staining with an antiserum against glial fibrillary acidic protein (GFAF' ), followed by light microscopic examination, indeed confirmed that astrocytes in both white and gray matter in the cat cortex possess GAFSAA receptors. (JHstochem Cytochem 41: 685-692, 1993) KEY WORDS: Cat; Visual cortex; Astrocyte; Immunocytochemistry; GABAA receptor.
Introduction
Recently, immunohistochemical studies using receptor antibodies have been performed that extended the previous autoradiographic GABAA receptor localizations (Chu et al., 1990; Needler et al., 1984) to the neuronal and even to the synaptic level (Soltesz et al., 1989; Somogyi et al., 1989) . At first these antibodies were raised against the entire GABAA receptor complex or against some of its subunits separately by using the entire subunit for immunization (Richards et al., 1987) . The knowledge of the amino acid sequence of some of these subunits (Bateson et al., 1990; Ymer et al., 1989; Schofield et al., 1987) provided us with the tools to produce receptor antibodies using small synthetic peptide fragments. In this way it is possible to direct the antibodies against a fragment that is located at the surface of the cell, optimizing the recognition of the receptor by the antibody.
Astrocytes have been implicated in the metabolism of GABA Supported by grants from the Queen Elisabeth Medical Foundation and the University Research Council (Katholieke Universiteit Leuven). (Battaglioli and Martin, 1991; Walz, 1989) , and it has been shown that chloride channels are involved in the GABA-induced depolarization of astrocytes (Hoppe and Kettenmann, 1989; Bormann and Kettenmann, 1988; Kettenmann et al., 1984 Kettenmann et al., , 1987 . However, until now only GABAB (Hosli and Hosli, 1990 ) and benzodiazepine (Bender and Hertz, 1988) receptors have been reported to be present on astrocytes. Therefore, our aim was to identify immunocytochemically GABAA receptors on astroglial cells using monoclonal antibodies (MAb) raised against a synthetic peptide fragment derived from the PI-subunit of the bovine GABAA receptor (Schofield et al., 1987) .
Materials and Methods

Preparation of the Conjugate and Immunization
A nine amino-acid peptide (NH2-His-Ser-Ala-Asn-Glu-Pro-Ser-Asn-Met) was synthesized. This peptide corresponded to an extracellular sequence located close to the N-terminal part of the PI-subunit of the bovine GABAA receptor, in the vicinity of an N-glycosylation site (Schofield et al., 1987) .
For immunization, the peptide was conjugated with thyroglobulin using carbodiimide as linking agent. To this was added 30 mg thyroglobulin (Sigma; Bornem, Belgium) dissolved in 2 ml PBS, pH 7.4, together with ROSIER, ARCKENS, ORBAN, V A N D E S N E 2.5 mg of the Pi-subunit peptide; 1.5 mg carbodiimide (EDC) (Sigma) dissolved in 0.5 ml MilliQ water was added, and the mixture was incubated overnight at room temperature in an end-over-end mixer (Analis; Gent, Belgium). The reaction was then blocked by the addition of 10 ml of a 1 M hydroxylamine solution for 3 hr at room temperature. All chemicals were purchased from Sigma. After dialysis, the conjugates were aliquotted in fractions, each containing approximately 200 pg of the peptide, and lyophylized. They were stored at -25°C until further use for immunization of mice and for immunoblotting specificity tests.
For immunization. 1 ml of conjugate, containing 200 pg conjugated peptide, was thoroughly mixed with 1 ml of complete Freund's adjuvant (Difco; Detroit. MI) and used to immunize four mice. The emulsion was injected subcutaneously at four separate sites on the back of the mice, and this procedure was repeated twice at 3-week intervals. For the following two injections, similar emulsions were prepared using incomplete Freund's adjuvant (Difco) . From the third injection on, blood samples were collected 2 days after injection. The samples were centrifuged immediately at 4000 rpm and screened immunocytochemically on sections of rat and cat cerebral cortex. The mice giving the best results in immunocytochemistry were used for the production of monoclonal antibodies. The MAb were also screened immunocytochemically on sections of cat visual cortex.
Animals and Tissue Preparation
Six adult rats (280-400 g, Sprague-Dawley) and three cats (2-2.5 kg. Fefir CUWJ) were used for immunocytochemistry. Three fiitives were examined, each tested on cerebral cortical sections of two rats: 2% paraformaldehyde, 2% paraformaldehyde supplemented with 1.25% glutaraldehyde, and Bouin-Hollande sublimate. All chemicals used in the fixatives were purchased from Sigma. Of these fitives, only fixation with the two 2% padormaldehyde solutions gave positive results. Hence, we perfused one cat with 2 % paraformaldehyde only and two cats with the 2% paraformaldehyde/1.25 % glutaraldehyde mixture. The paraformaldehydelglutaraldehyde mixture produced considerably less background staining and was further used for immunocytochemical single and double staining in cat visual cortex.
The animals were sacrificed with a large dose of pentobarbital (60 mg/kg) (Abbott Laboratories; Brussels, Belgium) and the brains were fixed in situ by cardiac perfusion with an 0.15 M sodium phosphate buffer, containing 2% paraformaldehyde supplemented with 1.25% glutaraldehyde (pH 7.4). The brains were subjected to a 24-hr post-fixation in the same phosphate buffer containing 2% paraformaldehyde only. They were rinsed overnight in water, and 50-pm vibratome (Vibratome; Oxford Instruments, UK) sections were cut and collected in a 24-well plate (Nunc; Kamstrup, Denmark). Before immunocytochemistry, the sections were incubated in a 2% NaB& solution for 5 min to reduce the free glutaraldehyde groups.
Immunocytochemistry
The immunocytochemical stainings were performed according to the procedure described by Sternberger et al. (1970) and Vandesande (1983) .
We compared the detection of the GABAA receptor in the cat visual cortex with the MAb produced as outlined above with that used previously in the cat central nervous system (Soltesz et al., 1989; Somogyi et al., 1989; Richards et al., 1987) , the bd-17 antibody (gift from Dr. Richards, Hdmann-La Roche). Both antibodies (supernatant, 1:1) were detected with biotinylated goat anti-mouse immunoglobulin G (diluted 1350) (Prosan; Gent, Belgium), followed by peroxidase-conjugated streptavidin (diluted 1:600) (Prosan) or by alkaline phosphatase-conjugated avidin (diluted 1:150) (Prosan). Peroxidase activity was detected with diaminobenzidine (DAB) (Sigma) and H202 (Merck; Leuven, Belgium), resulting in a brown reaction product, whereas alkaline phosphatase was detectid with Fast Blue BB (Serva-Poly-Absorption spectra lab; Merksem, Belgium) and naphthol-AS-MX phosphate (Serva-Polylab), resulting in a blue color. For details of both detection protocols, see Demeulemeester et al. (1991) . The polyclonal antiserum against glial fibrillary acidic protein (rabbit aGFAP, diluted 1:4000) (Amersham; Gent, Belgium) was detected with peroxidase-or alkaline phosphatase-conjugated swine anti-rabbit IgG (both diluted 1:lSO) (Prosan), resulting in a brown or blue staining, respectively.
With the double immunostaining technique, a very weak first sequence staining may be masked by a very strong second sequence staining. Therefore, the absorption spectra of cytoplasmic staining in astrocytes were made using a scanning microdensitometer (Vickers M86; Vickers Instruments, York, England). The optical density was measured at different wavelengths (400-600 run, with 1O-nm intervals). Comparison of the spectra of doublestained astrocytes with those of perikarya from single-stained control sections, showing a single DAB staining and a single Fast Blue BB staining, makes it possible to decide whether or not mixed staining is present.
These spectra are compared in Figure 1 . Although the absolute density values depend on staining intensity and can therefore vary, the slopes will remain similar. Therefore. a simple rule can distinguish between the three staining patterns: a double-stained perikaryon will absorb equally long and short wavelengths, whereas a single brown-stained perikaryon will absorb more at short than at long wavelengths, and a single blue-stained perikaryon will absorb more at long than at short wavelengths. The measurement of these spectra enabled us to unambiguously distinguish the three staining patterns each time that the visual impression was unclear.
GABAA Receptor Aflinity Chromatography
Sample Preparation. Unfixed liquid nitrogen-frozen cat cortical gray matter was homogenized with a Waring blendor (Ultra-Turrax; Janke & Kunkel, Staufen, Germany) in a 5 mM HEPES (Serva-Polylab) buffer (pH 7.4). The homogenate was centrifuged at 1000 x g for 10 min. The supernatant was subjected to another centrifugation for 10 min at 1000 x g, and the supernatant obtained from this latter centrifugation was then centrifuged for 10 min at 10.000 x g.
The pellet was then re-suspended in an 0.05 M citrate (Merck) solution (pH 7.4). containing 2 % (vlv) Triton X-100 (Sigma) for 2 hr at room temperature to solubilize all membrane proteins (Gavish and Snyder, 1981) . The supematant was used as a crude, protein extract and was dialyzed overnight in MilliQ water (1500 v/v) at 4'C to eliminate the salts and to remove all traces of Triton x-100.
To limit somewhat the amount of proteins applied to the affinity gel, the protein samples were then filtered on molecular weight basis with a 100-KD and a 100 KD filter (DIAFID Uldiltration membranes YMlOO and YM10, respectively; Amicon, Danvers, MA). Both fractions were treated simultaneously but separately.
Preparation of Affiity Gel. In a small preliminary test we examined the binding capacity of the CNBr-activated Sepharose 4B gel (Pharmacia; Brussels, Belgium) for GABA, using [3H]-GABA (Amersham) as tracer. Three affinity columns were prepared using 200 pmol [ 'HI-GABA and 200 pmol unlabeled GABA (Sigma) for each gel. The applied solutions as well as the free and gel-bound fractions were measured by liquid scintillation counting (P-counter) (Canberra Packard; Zellik, Belgium), revealing a coupling efficiency of 30-35%.
Two 6-ml GABA affinity gels were prepared using a stock solution containing 40 pmol GABA/100 ml. Considering the amount of GABA brought onto one gel (2400 nmol on a 6-ml gel) and the gel's binding capacity (30-35%), approximately 750 nmol GABA were presumed to be bound on each gel. Affiity Chromatography. After the protein samples had been applied to the affinity column, either of two elution procedures were used, with equally satisfying results
In one approach (acidification), the proteins bound to the affiity column were eluted with an 0.1 M glycine buffer (pH 2.8). Altematively, GABA receptor proteins were eluted by application ofthe GABAA receptor agonist muscimol Uanssen Chimica; Geel, Belgium) to the gel (1 pnol muscimol compared with approximately 750 nmol GABA), resulting in a competition between muscimol and GABA to occupy the GABA binding site on the P-subunit. SDSPAGE and Immunoblotting. Protein samples obtained after affinity chromatography, as well as control samples, containing all proteins solubilized from the membranes of cat cortical gray matter were denatured with sodium dodecyl sulfate (SDS) (Sigma) before PAGE on an 8-25% Phastgel gradient (MW range 6-300 KD) (Pharmacia) in an appmtus for horizontal electrophoresis (PhastSystem; Pharmacia).
The electrophoretically separated proteins were electroblotted onto a polyvinyl difluoride (PVDF) (Amersham) membrane. The membrane was then processed either for general protein detection (silver staining) or specific immunodetection.
The silver staining solution was composed of 0.4 ml 40% (w/v) trisodium citrate (Merck), 0.4 ml20% (w/v) FeSO4.7 HzO (Merck) in 9 ml distilled water; under vigorous stirring, 0.1 ml 20% AgN03 (UCB-Bioproducts; Eigenbrakel, Belgium) was added. After two 5-min rinses in distilled water, the PVDF membrane was stained in the staining solution under gentle agitation and subsequently rinsed in distilled water for a few seconds.
The immunodetection procedure was similar to the one used for immunocytochemistry on sections, but before the staining the PVDF membrane was incubated in a 5% bovine serum albumin (BSA) (Merck) solution for at least 1 hr at room temperature.
Immunoadsorption Specificity Tests
Immunoadsorption studies were performed to examine the specificity of the monoclonal antibodies. A constant, optimal dilution of the antiserum was incubated for 4 days at 4'C with various concentrations of (a) the con-jugate used for immunization, (b) the free B1-subunit peptide, or (c) the protein solution obtained after GABA receptor affinity chromatography.
The adsorbed antisera were then tested (a) for their immunocytochemical staining pattern on sections of cat visual cortex and (b) for their immunoreaction on crude protein extracts and on affinity-purified GABA receptor on blots.
Results
Immunocytochemical Screening of the Polyclonal Antibodies
From the third injection on. blood samples obtained after immunization with the peptide derived from the GABAA receptor PIsubunit, immunoreactive cells were observed throughout virtually all layers of the rat cerebral cortex and the cat visual cortex ( Figure  2A ). This prompted us to start hybridoma production and to characterize the resulting monoclonal antibodies.
GABAA Receptor Afinity Chromatography and
Since we did not know whether or not the receptor would be dissociated into its subunits by the solubilization procedure, we examined two fractions of proteins separately: the 10-100 KD and the >loo KD range. The results obtained with these two fractions were similar, and only the results for the heavy fraction are shown. SDS-PAGE on an 8-25 % gradient gel (PhastGel; Pharmacia), followed by a general protein detection, revealed that after affinity chromatography both the amount and the MW range of proteins present in the extracts were severely reduced (compared Lane 1 with Lanes 3 and 4 in Figure 3) . In Lanes 3 and 4, several protein bands were observed throughout the entire MW range. However, the densest and also the broadest protein band occurred between the molecular markers of 43 and 67 KD.
SDS-PAGE
Immunoblotting and Immunoadsorption
Immunoblotting clearly showed that the proteins recognized by the MAb (Figure 3, Lanes 5 , 6, and 7) were confined to the MW range of 43-67 KD. The other protein bands present in the gel were not labeled by these antibodies (Figure 3) . Whereas immunoblotting on the crude protein extract (Lane 5 in Figure 3 ) revealed a faint and spread immunopositive zone, immunodetection with either our own monoclonal (Lane 6 in Figure 3 ) or the bd-17 antibody (Lane 7 in Figure 3) on the affinity-purified receptor (subunits) revealed a sharp immunoreactive protein band. Moreover, as shown in Figure 4 , the immunostaining was completely abolished when either (a) 100 pg of the conjugate used for immunization, (b) 50 pg of the pure Pl-subunit peptide, or (c) 100 pg of the lyophilized sample obtained after affinity chromatography was added to 5 ml supernatant.
Immunocytochemistry
Glls that are devoid of GABAA receptors showed no positive staining with our monoclonal antibody, as examined in this study on sections of mouse liver fixed in a way similar to the fixation used II 111 IV , PI-subunit, and (D) the bd-17 antibody. The  cortical layering (I-VI) is indicated. wm, white matter. Bars = 50 bm.
Figure 2. Immunocytochemical detection of cells in (A) the whole or (E-D) parts of the cat visual cortex (Area 17) using (A) a polyclonal antibody, demonstrating the presence of GAMA-receptor-IR cells throughout all cortical layers, (E. C) the monoclonal antibodies raised against a nine aminc-acid peptide derived from the G A M A receptor
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' ql c for sections of cat visual cortex (2% paraformaldehyde/l.25% glutaraldehyde).
In the cat visual cortex, cells labeled with the monoclonal antibodies displayed a range of morphology and were found throughout all cortical layers, as well as within the subcortical white matter (Figures 2A and 2B) . In particular, both in rat cerebral and cat visual cortex, positive cells with glia-like morphology were observed ( Figures 2B and 5) . With our own antibody, such cells were observed in both the white and the gray matter, whereas with the bd-17 antibody we observed them only in the white matter. Moreover, astrocytes in the gray matter were concentrated in Layers I, VI, and V. They were less prominent in Layers I1 and 111 and were virtually absent from Layer IV.
In the cat striate cortex, the general laminar distribution of neurons immunostained with our monoclonal antiserum was similar to the one we observed with the bd-17 antibody, although the cell staining of these two antibodies clearly differed (Figures 2C and  2D) . Whereas the bd-17 antibody stained only the cell membrane the detection of the GABAA, receptor and glial fibrillary acidic protein (GFAP). Related to the differential staining of the two antibodies. the double staining in the cortical gray matter was observed mainly with our own antibody, whereas double staining in the subcortical white matter was seen with the two antibodies (our own MAb and the bd-17 antibody). When we labeled the receptor with peroxidases in brown and astrocytes with alkaline phosphatase in blue (or vice vena). two distinct cell populations were observed: neurons that were positive only for the receptor and GFAP-positive astrocytes displaying receptor immunoreactivity (Figure 5) . It is important to stress that thew mults were obtained independently of which detection system was coupled to the antibody.
All cells stained with the rabbit anti-GFAP serum exhibited GABAA receptor immunoreactivity. All astrocytes showed immunoreactivity for the receptor at the cell membrane level. and the majority were also labeled throughout the cytoplasm ( Figure  5) . In addition, and as expected. a large fraction of cortical cells positive for the GABAA receptor were non-glial cells and therefore remained singly stained.
Close contacts were observed betwten astrocytes and GABAA receptor-positive neurons ( Figure 5F ), although the significance of this observation is limited since we used only light microscopy.
To make certain that we had made a reliable distinction betwcen single-stained astrocytes (observed in the single immunostaining as well as in the control staining of the double immunostaining) and double-labeled astrocytes (observed in all double staining), we analyzed the absorption spectra of stained cell bodies. As can be Seen in Figure 1 . these spectra enabled us to differentiate between single-and double-stained astrocytes.
Discussion
Knowledge of the amino acid sequence of different subunits of a receptor supplies us with the tools to raise antibodies directed against a specific receptor subunit by using small synthetic peptide fragments, enhancing the detecting capabilities.
To test the specificity of the observed immunoreaction and in view of the possible application of these antibodies to sections of cat visual cortex. we isolated the GABAA receptor from similar tissue by affinity chromatography and characterized the antibodies by SDS-PAGE followed by immunoblotting and by immunoadsorption.
SDS-PAGE after GABAA receptor-aRinity chromatography, followed by a general protein detection. revealed the densest and also the broadest protein band between the molecular markers of 43 and 67 KD, corresponding to the known variety in molecular weights of the GABAA receptor subunits, together with their intravariability in isoforms. SDS-PAGE followed by electroblotting and immunocytochemical detection with the monoclonal antibodies revealed two similarly labeled bands centered around 55-60 KD. corresponding to the molccularweightsofxved (a-and) P-subunit variants of the GABAA receptor (Richards et al.. 1987; Schofield et al.. 1987) .
Although we do not know the exact isoform(s) of the 8-subunit that are recognized by our monoclonal antibody, the proteins recognized on a Western blot lie in the proximity of the proteins rec-ognized by the bd-17 antibody, which have been reported to recognize both P 2 -and P3-subunits, displaying a single protein band around 56-58 KD (Benke et al., 1991) . Therefore, supplemented by the immunoadsorption studies, we have reason to believe that our monoclonal antiserum indeed recognizes a P-subunit isoform of the GABAA receptor.
Since the peptide used for immunization in this study was derived from the bovine Pi-subunit (Schofield et al., 1987) , we examined the presence of this small amino acid sequence in other B-subunit isoforms characterized thus far in several species. The bovine PI-subunit peptide (amino acid position 26-34) shares an identical six-amino-acid sequence with both the human and the rat (Ymer et al., 1989) pi-subunit peptide at that location. In addition, the selected bovine 61-subunit peptide also shares a four amino-acid sequence with the rat P2-subunit (Ymer et al., 1989) , whereas comparison with the rat or thechicken 83-subunit reveals only an identical two-amino-acid sequence at that location. Hence, we are tempted to believe that our MAb raised against a synthetic peptide derived from the bovine Pi-subunit of the GABAA receptor recognizes mainly the PI-subunit and, perhaps, to a lesser extent also the Pz-subunit. This might explain the similarity in the SDS-PAGE-immunoblotting results between our monoclonal antibody and the bd-17 antibody, since the molecular weight of the different subunits appears equal for these methods. On the other hand, it is difficult to see how it could explain the
